Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 403.15
-6.70 (-1.63%)
At close: Oct 16, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 40.43 billion as of October 16, 2026. It is the 15,726th most valuable company in the world and the 940th biggest in India. Its market cap has increased by 11.31% in one year.
Market Cap
40.43B
Enterprise Value
43.85B
Revenue
9.81B
Global Rank
Country Rank
#940 India
PE Ratio
55.06
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 40.43B, an increase of 11,220.31%. That is a compound annual growth rate of 20.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 40.43B | 19.72% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 69.75B |
| Morepen Laboratories | 68.82B |
| Sanofi India | 68.11B |
| FDC Limited | 57.19B |
| Evonile Pharma | 47.83B |
| Unichem Laboratories | 36.62B |
| Kwality Pharmaceuticals | 34.41B |
| Shukra Pharmaceuticals | 29.35B |